Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Malays J Pathol ; 41(1): 71-73, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31025642

RESUMEN

INTRODUCTION: Intratumoral calcification is a feature that is more often observed in pineal parenchymal tumour than germinoma. We describe a 13-year-old male with pineal region germinoma demonstrating extensive intratumoral calcification. CASE REPORT: He presented with worsening headache that was associated with fatigue, nausea and vomiting. Radiologic examination revealed a multilobular mass in the pineal region with internal calcifications. Biopsy showed a pure germinoma with unusually extensive calcification. DISCUSSION: Although a diagnosis may be suggested with a careful evaluation of imaging, there is no pathognomonic pattern. Thus, histologic verification is necessary for most pineal region masses.


Asunto(s)
Calcinosis/patología , Germinoma/patología , Pinealoma/patología , Adolescente , Humanos , Masculino
3.
Hum Pathol ; 32(5): 513-20, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11381370

RESUMEN

Mixed epithelial and stromal tumor of the kidney is a recently recognized neoplasm that occurs almost exclusively in perimenopausal women. Because it frequently contains areas of smooth muscle in which epithelial structures are embedded, some have concluded that it is the adult form of congenital mesoblastic nephroma. Others have concluded that the morphology and epidemiology of mixed epithelial and stromal tumor indicate that it is unrelated to congenital mesoblastic nephroma. Although the genetic alterations of mixed epithelial and stromal tumor have not been previously elucidated, much is known about the genetic alterations of cellular congenital mesoblastic nephroma. The present study was undertaken to determine if mixed epithelial and stromal tumors have any of the genetic alterations recognized as typical of cellular congenital mesoblastic nephroma. RNA extraction was performed on formalin-fixed, paraffin-embedded tissue from 7 mixed epithelial and stromal tumors followed by reverse-transcription polymerase chain reaction to detect the ETV6-NTRK3 gene fusion. Fluorescent in situ hybridization with centromere-specific probes for chromosomes 8, 11, and 17 was performed to evaluate polyploidy of these chromosomes in 11 cases of mixed epithelial and stromal tumor. None of the mixed epithelial and stromal tumors showed any of these genetic alterations. We conclude that mixed epithelial and stromal tumor of the kidney lacks the genetic alterations typical of cellular congenital mesoblastic nephroma, is unrelated to it, and the appellation "adult mesoblastic nephroma" should not be used for these tumors.


Asunto(s)
Células Epiteliales/patología , Neoplasias Renales/genética , Nefroma Mesoblástico/congénito , Nefroma Mesoblástico/genética , Proteínas Represoras , Células del Estroma/patología , Adulto , Anciano , Cromosomas Humanos Par 11 , Cromosomas Humanos Par 17 , Cromosomas Humanos Par 8 , Proteínas de Unión al ADN/genética , Femenino , Humanos , Hibridación Fluorescente in Situ , Neoplasias Renales/patología , Menopausia , Persona de Mediana Edad , Proteínas de Fusión Oncogénica , Ploidias , Proteínas Proto-Oncogénicas c-ets , Receptor trkC/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Transcripción/genética , Translocación Genética , Proteína ETS de Variante de Translocación 6
4.
Int J Exp Diabetes Res ; 2(3): 187-93, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-12369706

RESUMEN

In order to explore the neuroprotective and cross-species activities of C-peptide on type 1 diabetic neuropathy, spontaneously diabetic BB/W-rats were given increasing doses of human recombinant C-peptide (hrC-peptide). Diabetic rats received 10, 100, 500, or 1000 microg of hrC-peptide/kg body weight/day from onset of diabetes. After 2 months of hrC-peptide administration, 100 microg and greater doses completely prevented the nerve conduction defect, which was associated with a significant but incomplete prevention of neural Na+/K+-ATPase activity in diabetic rats with 500 microg or greater C-peptide replacement. Increasing doses of hrC-peptide showed increasing prevention of early structural abnormalities such as paranodal swelling and axonal degeneration and an increasing frequency of regenerating sural nerve fibers. We conclude that hrC-peptide exerts a dose dependent protection on type 1 diabetic neuropathy in rats and that this effect is probably mediated by the partially conserved sequence of the active C-terminal pentapeptide.


Asunto(s)
Péptido C/farmacología , Neuropatías Diabéticas/prevención & control , Conducción Nerviosa/fisiología , Animales , Glucemia/metabolismo , Péptido C/sangre , Diabetes Mellitus Tipo 1/fisiopatología , Neuropatías Diabéticas/fisiopatología , Relación Dosis-Respuesta a Droga , Humanos , Insulina/uso terapéutico , Cinética , Masculino , Fibras Nerviosas/efectos de los fármacos , Fibras Nerviosas/fisiología , Conducción Nerviosa/efectos de los fármacos , Ratas , Ratas Endogámicas BB , Proteínas Recombinantes/sangre , Proteínas Recombinantes/farmacología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Nervio Sural/efectos de los fármacos , Nervio Sural/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...